Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer

Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

(2016) Dharanija Madhavan et al.   CARCINOGENESIS

Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

(2015) Shota Tanaka et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR

(2015) Francesco Marabita et al.   BRIEFINGS IN BIOINFORMATICS

High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation

(2015) Hyo Jung Cho et al.   CLINICAL BIOCHEMISTRY

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer

(2015) Xiaofeng Zheng et al.   NATURE

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

(2015) Kari R. Fischer et al.   NATURE

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

(2014) Marek Sochor et al.   BMC CANCER

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients

(2014) M Pichler et al.   BRITISH JOURNAL OF CANCER

Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer

(2014) J. Ristau et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo

(2014) Jinxia He et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines

(2014) Tania Diaz et al.   JOURNAL OF SURGICAL ONCOLOGY

Protection From Colorectal Cancer After Colonoscopy

(2013) Hermann Brenner et al.   ANNALS OF INTERNAL MEDICINE

Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer

(2013) Yuji Toiyama et al.   ANNALS OF SURGERY

Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis

(2013) Ichirota Iino et al.   CANCER SCIENCE

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

(2013) Verena Köberle et al.   EUROPEAN JOURNAL OF CANCER

Predicting distant metastasis and chemoresistance using plasma miRNAs

(2013) Jianmei Chen et al.   MEDICAL ONCOLOGY

Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer

(2013) Xiaoya Luo et al.   PLoS One

The Role of MicroRNA-200 in Progression of Human Colorectal and Breast Cancer

(2013) Linda Bojmar et al.   PLoS One

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

(2012) D. Madhavan et al.   CLINICAL CANCER RESEARCH

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis

(2012) Keun Hur et al.   GUT

Circulating microRNAs in plasma as early detection markers for breast cancer

(2012) Katarina Cuk et al.   INTERNATIONAL JOURNAL OF CANCER

Assessing sample and miRNA profile quality in serum and plasma or other biofluids

(2012) Thorarinn Blondal et al.   METHODS

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

(2011) C. C. Pritchard et al.   Cancer Prevention Research

Characterization of extracellular circulating microRNA

(2011) Andrey Turchinovich et al.   NUCLEIC ACIDS RESEARCH

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

(2011) Hanyin Cheng et al.   PLoS One

Haemolysis during Sample Preparation Alters microRNA Content of Plasma

(2011) Michaela B. Kirschner et al.   PLoS One

Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases

(2010) Y. Zhang et al.   CLINICAL CHEMISTRY

Circulating miRNAs are correlated with tumor progression in prostate cancer

(2010) Jan C. Brase et al.   INTERNATIONAL JOURNAL OF CANCER

The miR-144/451 locus is required for erythroid homeostasis

(2010) Kasper D. Rasmussen et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

(2010) Evan M. Kroh et al.   METHODS

The miR-200 Family: Central Player for Gain and Loss of the Epithelial Phenotype

(2009) Simone Spaderna et al.   GASTROENTEROLOGY

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

(2009) Ulrich Wellner et al.   NATURE CELL BIOLOGY

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

(2009) C Coulouarn et al.   ONCOGENE

miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases

(2009) Derek M. Dykxhoorn et al.   PLoS One

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

(2008) Wei-Chih Tsai et al.   HEPATOLOGY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA